TY - JOUR
T1 - A Mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice
AU - Colomer Gould, Veronica F.
AU - Goti, Daniel
AU - Pearce, Donna
AU - Gonzalez, Guillermo A.
AU - Gao, Hong
AU - Bermudez de Leon, Mario
AU - Jenkins, Nancy A.
AU - Copeland, Neal G.
AU - Ross, Christopher A.
AU - Brown, Dale R.
N1 - Funding Information:
We especially thank: (a) Debbie Swing for performing the zygote injections; (b) Mrs. Mary Keyser and Suzanne Fowble for budget administration; and (c) Dr. Pamela Talalay for critical editing of the manuscript. This work was supported by: (a) Donation from JCG (VCG); (b) NIH grant NS42731-01 (VCG); (c) AHA grant EIG 0140166N (VCG); and in part by (d) NIH Intramural Research Program, National Cancer Institute, Center for Cancer Research (NAJ, NGC).
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/9/1
Y1 - 2007/9/1
N2 - Machado-Joseph disease also called spinocerebellar ataxia type 3 (MJD/SCA3) is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a polyglutamine expansion (mutant ataxin-3). Neuronal loss in MJD/SCA3 is associated with a mutant ataxin-3 toxic fragment. Defining mutant ataxin-3 proteolytic site(s) could facilitate the identification of the corresponding enzyme(s). Previously, we reported a mutant ataxin-3 mjd1a fragment in the brain of transgenic mice (Q71) that contained epitopes C-terminal to amino acid 220. In this study, we generated and characterized neuroblastoma cells and transgenic mice expressing mutant ataxin-3 mjd1a lacking amino acids 190-220 (deltaQ71). Less deltaQ71 than Q71 fragments were detected in the cell but not mouse model. The transgenic mice developed an MJD/SCA3-like phenotype and their brain homogenates had a fragment containing epitopes C-terminal to amino acid 220. Our results support the toxic fragment hypothesis and narrow the mutant ataxin-3 cleavage site to the N-terminus of amino acid 190.
AB - Machado-Joseph disease also called spinocerebellar ataxia type 3 (MJD/SCA3) is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a polyglutamine expansion (mutant ataxin-3). Neuronal loss in MJD/SCA3 is associated with a mutant ataxin-3 toxic fragment. Defining mutant ataxin-3 proteolytic site(s) could facilitate the identification of the corresponding enzyme(s). Previously, we reported a mutant ataxin-3 mjd1a fragment in the brain of transgenic mice (Q71) that contained epitopes C-terminal to amino acid 220. In this study, we generated and characterized neuroblastoma cells and transgenic mice expressing mutant ataxin-3 mjd1a lacking amino acids 190-220 (deltaQ71). Less deltaQ71 than Q71 fragments were detected in the cell but not mouse model. The transgenic mice developed an MJD/SCA3-like phenotype and their brain homogenates had a fragment containing epitopes C-terminal to amino acid 220. Our results support the toxic fragment hypothesis and narrow the mutant ataxin-3 cleavage site to the N-terminus of amino acid 190.
UR - http://www.scopus.com/inward/record.url?scp=34548329581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548329581&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/6ed836a8-985c-325e-8a45-bc0f4d35d256/
U2 - 10.1016/j.nbd.2007.06.005
DO - 10.1016/j.nbd.2007.06.005
M3 - Article
C2 - 17632007
SN - 0969-9961
VL - 27
SP - 362
EP - 369
JO - Neurobiology of Disease
JF - Neurobiology of Disease
IS - 3
ER -